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ABSTRACT 25 
Testudinid herpesvirus 3 (TeHV-3) is the causative agent of a lethal disease affecting several 26 
tortoise species. The threat that this virus poses to endangered animals is focusing efforts on 27 
characterizing its properties, in order to enable the development of prophylactic methods. We 28 
have sequenced the genomes of the two most studied TeHV-3 strains (1976 and 4295). 29 
TeHV-3 strain 1976 has a novel genome structure and is most closely related to a turtle 30 
herpesvirus, thus supporting its classification into genus Scutavirus, subfamily 31 
Alphaherpesvirinae, family Herpesviridae. The sequence of strain 1976 also revealed viral 32 
counterparts of cellular interleukin-10 and semaphorin, which have not been described 33 
previously in members of subfamily Alphaherpesvirinae.  TeHV-3 strain 4295 is a mixture of 34 
three forms (m1, m2, and M), in which, in comparison to strain 1976, the genomes exhibit 35 
large, partially overlapping deletions of 12.5 to 22.4 kb. Viral subclones representing these 36 
forms were isolated by limiting dilution, and each replicated in cell culture comparably to 37 
strain 1976. With the goal of testing the potential of the three forms as attenuated vaccine 38 
candidates, strain 4295 was inoculated intranasally into Hermann’s tortoises (Testudo 39 
hermanni). All inoculated subjects died, and PCR analyses demonstrated the ability of the m2 40 
and M forms to spread and invade the brain. In contrast, the m1 form was detected in none of 41 
the organs tested, suggesting its potential as the basis of an attenuated vaccine candidate. Our 42 
findings represent a major step towards characterizing TeHV-3 and developing prophylactic 43 
methods against it.  44 
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IMPORTANCE 45 
 46 
Testudinid herpesvirus 3 (TeHV-3) causes a lethal disease in tortoises, several species of 47 
which are endangered. We have characterized the viral genome, and used this information to 48 
take steps towards developing an attenuated vaccine. We have sequenced the genomes of two 49 
strains (1976 and 4295), compared their growth in vitro, and investigated the pathogenesis of 50 
strain 4295, which consists of three deletion mutants. The major findings are: (i) TeHV-3 has 51 
a novel genome structure; (ii) its closest relative is a turtle herpesvirus; (iii) it contains 52 
interleukin-10 and semaphorin genes, the first time these have been reported in an 53 
alphaherpesvirus; (iv) a sizeable region of the genome is not required for viral replication in 54 
vitro or virulence in vivo; and (v) one of the components of strain 4295, which has a deletion 55 
of 22.4 kb, exhibits properties indicating that it may serve as the starting point for an 56 
attenuated vaccine. 57 
58 
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INTRODUCTION 59 
The order Herpesvirales contains a large number of enveloped, double-stranded DNA 60 
viruses that share structural, genetic and biological properties, and is divided into three 61 
families infecting a wide range of hosts (1). One of these families, the Herpesviridae, contains 62 
viruses infecting mammals, birds, or reptiles, and is subdivided into three subfamilies, the 63 
Alpha-, Beta-, and Gammaherpesvirinae (2). Members of these subfamilies are referred to 64 
colloquially as alpha-, beta-, and gammaherpesviruses, respectively. 65 
All herpesviruses of reptiles identified to date group among the alphaherpesviruses, in 66 
lineages distinct from herpesviruses of mammals or birds (3). Many of the hosts of these 67 
viruses belong to the order Testudines (also called Chelonii), and include pond turtles, marine 68 
turtles, and terrestrial tortoises. Among members of the order Testudines, herpesvirus 69 
infections have been described chiefly in the latter two groups. Among marine turtles, the 70 
genome of chelonid herpesvirus 5 (ChHV-5), which is thought to be the causative agent of 71 
fibropapillomatosis, has been cloned as a bacterial artificial chromosome from infected tissue 72 
and sequenced. This virus has been classified into the genus Scutavirus (4). The phylogenetic 73 
relationship between herpesviruses infecting marine turtles and those infecting tortoises is 74 
unclear (3). 75 
Tortoises exist as at least 40 species belonging to the family Testudinidae. 76 
Herpesviruses have been isolated from healthy or sick individuals belonging to several of 77 
these species. Based on partial sequencing of the viral DNA polymerase gene, four genotypes 78 
have been identified, leading to the nomenclature testudinid herpesvirus 1 to 4 (TeHV-1 to 79 
TeHV-4) (3). Among these genotypes, TeHV-3 appears to be the most pathogenic, and has 80 
been shown to affect several tortoise species, with those from the genus Testudo (e.g., Testudo 81 
hermanni) being the most sensitive (5, 6). Young tortoises are more susceptible to TeHV-3 82 
disease than adults, and can suffer from mortality rates of up to 100%. These pathological and 83 
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epidemiological features, and the fact that many of the susceptible host species are 84 
endangered, contribute to ecological concerns over this virus. Clinical signs depend on several 85 
factors, including host species, age, the season at which infection occurs, and the viral strain 86 
involved (7-12). The main clinical signs are nasal discharge, rhinitis, conjunctivitis associated 87 
with blepharospasm, and diphtheritic plaques in the oral cavity and esophagus (13). Weight 88 
loss, cachexia, central nervous symptoms (such as circling and head tilt), and death are 89 
observed in advanced stages of the disease. The virus has been isolated from several tissues, 90 
suggesting a broad tropism (8, 11, 14, 15). With the goal of controlling the threat that TeHV-3 91 
poses to tortoise populations, various inactivated vaccine candidates have been tested, but 92 
none has proved efficacious (16, 17). Obvious alternatives to inactivated vaccines are 93 
attenuated vaccines and subunit vaccines targeting key viral proteins. The knowledge required 94 
for the development of such vaccines would include the genome sequence. 95 
 Here, we sequenced the genomes of representative TeHV-3 strains 1976 (18) and 96 
4295 (9). Strain 1976 has a genome structure not reported previously among herpesviruses, 97 
and is most closely related phylogenetically to turtle herpesviruses. This strain also contains 98 
genes with cellular homologues that have not been described previously in 99 
alphaherpesviruses. Strain 4295 consists of a mixture of three forms, of which the genomes 100 
exhibit large, partially overlapping deletions in comparison with strain 1976. The effects of 101 
these deletions on viral growth in vitro and virulence in vivo were investigated. 102 
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MATERIALS AND METHODS 103 
Cells and viruses 104 
Terrapene heart cells (TH-1, subline B1) (19) were cultured in medium (Dulbecco’s 105 
modified Eagle’s medium (DMEM; Sigma-Aldrich) containing 4.5 g/L glucose, 5 % fetal calf 106 
serum, and 1 % non-essential amino acids (Invitrogen)). Cells were cultured at 25°C in a 107 
humid atmosphere in the presence of 5 % CO2. Two previously described TeHV-3 strains 108 
were used. Strain 1976 (passage 6) originated from the intestine of a Horsfield's tortoise (T. 109 
horsfieldii) that died from TeHV-3 infection (18).  Strain 4295 (passage 14) was isolated from 110 
a pharyngeal swab performed on a clinically healthy Hermann's tortoise (T. hermanni) during 111 
an outbreak of herpesviral disease (9). The absence of extraneous contaminating agents in the 112 
TH-1 cells and TeHV-3 strains was confirmed by electron microscopic examination of 113 
mock-infected and infected TH-1 cells (Fig. 1). Clones of strain 4295 were produced by 114 
limiting dilution. Ten-fold serial dilutions of infected culture supernatant were inoculated onto 115 
TH-1 cells grown in 96-well plates. Clones were amplified from dilutions for which less than 116 
10 % of the wells showed signs of infection. The purity and genotype of the clones were 117 
determined by PCR (see below; Fig. 7A and B). 118 
 119 
Virion DNA production 120 
Confluent TH-1 cells were infected with TeHV-3 at a multiplicity of infection (MOI) 121 
of 0.2 PFU/cell. To reduce contamination by cellular DNA, cell supernatant was harvested at 122 
the early stages of viral release, when approximately 10 % of cells were exhibiting cytopathic 123 
effect. Virions were semi-purified as described previously (20). Briefly, after removal of the 124 
cell debris by centrifugation (1000 g, 10 min, 4°C), viral particles were pelleted by 125 
ultracentrifugation through a 30 % sucrose cushion (100,000 g, 2 h, 4°C). DNA was purified 126 
from virions as described previously (21). 127 
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DNA sequencing 128 
 Virion DNA (1 µg) was sheared by sonication to an average size of 470 bp, and 129 
sequencing libraries were prepared by using a KAPA library preparation kit (KAPA 130 
Biosystems). The fragments were A-tailed and ligated to the NEBnext Illumina adaptor (New 131 
England Biolabs), and NEBnext indexing primers were added by carrying out four cycles of 132 
PCR in an ABI 7500 realtime cycler, using a KAPA HiFi Realtime library amplification kit. 133 
The libraries were sequenced by using a MiSeq (Illumina) operating v2 chemistry, generating 134 
data sets of 250 nucleotide (nt) paired-end reads. The reads were filtered for quality, adapter 135 
sequences were removed by using Trim Galore v. 0.2.2 136 
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore), and the reads were 137 
assembled by using Velvet v. 1.2.07 (22) and AbySS v. 1.3.5 (23). Larger contigs were 138 
generated from the assemblies by using Phrap v. 1.080812 (24, 25) and then IMAGE v. 2.31 139 
(26). The data sets were assembled against the contigs by using BWA v. 0.6.2-r126 (27), and 140 
the alignments were inspected by using Tablet 1.13.12.17 (28). Problematic regions, including 141 
those representing deletions or duplications, and those containing relatively short reiterated 142 
sequences (including mononucleotide tracts), were resolved by using custom Perl scripts to 143 
count and extract individual reads from the data sets for further analysis (29). The sizes of the 144 
more substantial reiterated sequences were estimated by PCR (Table 1), and, in most 145 
instances, the products were sequenced by using Sanger technology. 146 
 Potential genome termini were identified in the BWA alignments from sets of reads 147 
sharing a common end. They were confirmed for strains 1976 and 4295  (prior to subcloning) 148 
by using published methodology (30), which involves ligating partially double-stranded DNA 149 
adapters to blunt-ended or untreated viral DNA, followed by PCR using a combination of a 150 
virus-specific primer and an adapter-specific primer (the former are listed in Table 1). The 151 
inserts from 12 plasmids generated from each purified PCR product were sequenced by using 152 
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Sanger technology, and the genome termini were defined as being located at the positions 153 
represented by the majority of clones. Analysis of both blunt-ended and untreated viral DNA 154 
allowed unpaired nucleotides at the 3’-ends of the genome to be identified. The genome 155 
termini of the three subclones (m1, m2, and M) of strain 4295 were not determined in this 156 
way, but rather inferred from the data from strain 4295. The final genome sequences of strain 157 
1976 and the three subclones (m1, m2, and M) of strain 4295 were constructed on the basis of 158 
the locations of the termini, and the integrity of each was verified by aligning it against the 159 
relevant data set using BWA, visualizing the alignment by using Tablet. The sequences were 160 
deposited in NCBI GenBank (see below).  161 
Southern blot analysis 162 
Southern blot analysis of virion DNA, digested with EcoRI or KpnI restriction 163 
endonucleases, was performed as described previously (31, 32). Probes were produced by 164 
PCR amplification of strain 1976 DNA using specific primers (Table 1). 165 
Viral growth curves 166 
Triplicate cultures of TH-1 cells in 24-well plates were inoculated with TeHV-3 at an 167 
MOI of 0.2 PFU/cell. After an incubation period of 4 h, the cells were washed with PBS and 168 
overlaid with DMEM containing 4.5 g/liter glucose, 5 % FCS and 1 % non-essential amino 169 
acids (Invitrogen). The supernatants of infected cultures were harvested at successive 170 
intervals after infection and stored at -80°C. The amount of infectious virus was determined 171 
by plaque assay on TH-1 cells as described previously (32, 33). The data, expressed as mean 172 
titer and standard deviation (SD) of triplicate assays, were analyzed for significant differences 173 
(p<0.05) using one-way ANOVA. 174 
 175 
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Transmission electron microscopy 176 
TH-1 cells were infected with TeHV-3 at a MOI of 0.2 PFU/cell, and, at 6 days 177 
post-infection, processed for electron microscopic examination as described elsewhere (32). 178 
 179 
Tortoises 180 
Five-year old Hermann’s tortoises (T. hermanni) originating from a small colony bred 181 
in captivity were kept individually in terrariums (width x depth x height: 0.9 x 0.45 x 0.6 m). 182 
The environmental parameters were as follows. Relative humidity was maintained at 60-70 183 
%. Lighting was controlled automatically on standard 12 h light and 12 h dark circadian 184 
cycles, with a UVb light switched on during the 12 h light period. The temperature of an 185 
infrared basking spot was regulated at 29°C during the light period and 24°C during the dark 186 
period, respectively. A temperature gradient of approximately 6°C was present in the 187 
terrariums, with the basking spot being the warmest place. Fresh water and vegetables were 188 
provided daily. Clinical examinations of tortoises immediately prior to the experiments 189 
revealed that they were healthy. Experiments were preceded by an acclimatization period of 2 190 
weeks. 191 
Inoculation of tortoises with TeHV-3 192 
Tortoises were sedated with alfaxolone (Dechra Veterinary Products) injected intravenously 193 
at a dose of 7 mg/kg. TeHV-3 was then inoculated by intranasal instillation of 1x105 PFU 194 
distributed equally between both nostrils (total volume of 50 µl). The animals were examined 195 
twice daily until the end of the experiment. Animals expressing significant apathy, 196 
neurological signs, or respiratory distress were euthanized in accord with the end point 197 
defined by the local bioethics committee. 198 
 199 
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Ethics statement 200 
The experiments, maintenance, and care of tortoises complied with the guidelines of 201 
the European Convention for the Protection of Vertebrate Animals used for Experimental and 202 
other Scientific Purposes (CETS no. 123). The animal study was approved by the local ethics 203 
committee of the University of Liège, Belgium (laboratory accreditation no. LA 1610010, 204 
protocol no. 1217). All efforts were made to minimize suffering and to respect the 3Rs rule. 205 
Quantification of viral gene copies in organs by qPCR 206 
DNA was isolated from 25 mg of organs stored at -80°C in RNAlater (Invitrogen) by 207 
using a DNA mini kit (Qiagen). The viral genome was quantified by amplifying fragments of 208 
the TeHV-3 UL13 and T. hermanni β-actin genes, using real-time SYBR green-based PCR. 209 
The primers used are listed in Table 1. The qPCR reactions were performed using a CFX96 210 
Touch real-time PCR detection system and iTaq universal probe supermix as detection 211 
chemistry (Bio-Rad Laboratories). Master-mix for qPCR consisted of 1 x iTaq universal 212 
probe supermix, 200 nM each primer, and 200 ng sample DNA in a final volume of 15 μl. 213 
The UL13 amplification program included an initial denaturation step at 95°C for 3 min, 214 
followed by 50 cycles with a denaturation step at 95°C for 30 s, an annealing step at 58.5°C 215 
for 30 s, and an elongation step at 72°C for 30 s. The β-actin amplification program included 216 
an initial denaturation step at 95°C for 3 min, followed by 50 cycles with a denaturation step 217 
at 95°C for 30 s, an annealing step at 60°C for 30 s, and elongation step at 72°C for 30 s. At 218 
the end of these amplification programs, the dissociation stage was performed (95°C for 10 s), 219 
and the melting curve was determined by increasing the temperature from 60 to 95°C at the 220 
rate of 0.1°C/s. All reactions were carried out in triplicate. 221 
Data for validation of qPCR (efficiency (E), coefficient of determination (R²), and 222 
slope) were analyzed by using Bio-Rad CFX Manager 3.1 software (Bio-Rad Laboratories) 223 
with the auto method (UL13: E = 94.7 %, R² = 0.994, slope = -3.456; β-actin : E = 95.2 %, R² 224 
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= 0.982, slope = -3.443). The mean values of the number of TeHV-3 genome copies in 225 
various organs were compared by using the Kruskal-Wallis test. A value of p<0.05 was 226 
considered significant, and a value of p<0.01 was considered highly significant. 227 
Histological analyses 228 
Lung, spleen, brain (telencephalon), kidney, and liver from a mock-infected tortoise 229 
and from infected tortoises were dissected immediately after euthanasia, fixed in 10 % 230 
buffered formalin, and embedded in paraffin blocks. Sections of 5 μm were stained with 231 
hematoxylin and eosin prior to microscopic analysis (34). For each sample, ten randomly 232 
selected fields were examined in a blind test. 233 
Phylogenetic analyses 234 
Predicted amino acid sequences were obtained in this study or from GenBank. The 235 
raw phylogenetic data derived from them are available at 236 
http://dx.doi.org/10.17635/lancaster/researchdata/11. The sequences of herpesvirus DNA 237 
polymerases were aligned by using Muscle (35) in MEGA (36). A Bayesian tree was then 238 
constructed in BEAST (37), using the LG+Γ substitution model (38), a lognormal relaxed 239 
clock model (39), and a Yule speciation tree model (40). The tree was run to convergence, at 240 
which point all posterior probabilities on the nodes were 1. The amino acid sequence of 241 
TeHV-3 gene TE7, which encodes a semaphorin (SEMA)-related protein, was aligned with 242 
the sequences of SEMA-7s by using Muscle (35), before constructing a maximum likelihood 243 
tree in MEGA (36), using the LG+Γ substitution model (2). The amino acid sequence of 244 
TeHV-3 gene TE8, which encodes an interleukin-10 (IL-10)-related protein, was analyzed by 245 
using Treeadder (41) with a previously published tree (42), in order to create a set of trees 246 
with the TeHV-3 TE8 sequence added at every possible position. The likelihood of each tree 247 
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was assessed by using Tree-puzzle (43), and bootstrap significance was assessed by using 248 
Consel (44). 249 
Structural analyses 250 
Solved structures from PDB were selected for the SEMA and IL-10 protein families. 251 
Homology models for TeHV-3 SEMA and IL-10 were constructed in relation to these solved 252 
structures by using MOE 2014.09 (Chemical Computing Group, Montreal). Briefly, an initial 253 
partial geometry was copied from the template chains in the solved structures, using all 254 
co-ordinates in which residue identity was conserved. Otherwise, only backbone coordinates 255 
were used. Based on this initial geometry, Boltzmann-weighted randomized modelling (45) 256 
was employed, with segment searching for regions that could not be mapped onto the initial 257 
geometry (46). A total of 100 models were constructed. On completion of segment addition, 258 
each model was energetically minimized in the AMBER99 force field (47). The highest 259 
scoring intermediate model was then determined by the generalized Born/volume integral 260 
(GB/VI) methodology (48). Stereochemical quality of homology models was assessed using 261 
Ramachandran plots (49). 262 
 263 
Nucleotide sequences 264 
The genome sequences of TeHV-3 strain 1976 and the three subclones (m1, m2, and 265 
M) of strain 4295 were deposited in NCBI GenBank under accession numbers KM924292, 266 
KR363629, KR363628, and KM924293, respectively.   267 
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RESULTS AND DISCUSSION 268 
The initial goal of this study was to determine the sequence of the TeHV-3 genome. 269 
To achieve this, the two most studied isolates (strains 1976 and 4295) were sequenced. 270 
Analysis of high-throughput sequence data for strain 1976 indicated the presence of a single 271 
population, whereas that for strain 4295 implied the presence of a mixture of three closely 272 
related populations, each being most simply interpreted as a deletion mutant derived from an 273 
ancestral genome similar to that of strain 1976. 274 
Genome sequence of strain 1976 275 
The filtered data set for strain 1976 consisted of 3,787,248 reads, of which 1,488,829 276 
(39 %) aligned with the finished sequence at an average coverage of 2305 reads/nt. The 277 
genome is 160,358 bp in size, and consists of a central, long unique region (UL; 107,928 bp), 278 
extended at its right end by a short unique region (US; 20,375 bp) flanked by an inverted 279 
repeat (IRS and TRS; 8536 bp), and at its left end by a third unique region (UT; 12,595 bp) also 280 
flanked by an inverted repeat (TRT and IRT; 1194 bp), yielding the overall configuration 281 
TRT-UT-IRT-UL-IRS-US-TRS (Fig. 2). Each 3’-end of the genome consists of a single, 282 
unpaired nucleotide complementary to the nucleotide at the other 3’-end. All alphaherpesvirus 283 
genome structures share the UL-IRS-US-TRS component, in some cases with UL flanked by an 284 
inverted repeat to produce TRL-UL-IRL-IRS-US-TRS (2). However, the TRT-UT-IRT 285 
component is novel, yielding a genome structure that has not been reported previously in the 286 
family Herpesviridae. The alphaherpesvirus genomes most reminiscent of TeHV-3 in this 287 
regard are equid herpesviruses 1 and 4 (genus Varicellovirus), which contain a small inverted 288 
repeat (87 and 86 bp, respectively) at the left end of UL, separated from its counterpart by a 289 
short sequence (944 and 667 bp, respectively) (50, 51). However, the sizes of TRT/IRT and UT 290 
in TeHV-3 are much larger than in these viruses, and each contains protein-coding sequences 291 
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(see below). The average nucleotide composition of the strain 1976 genome is 46 % G+C, 292 
with TRT/IRT, UT, UL, TRS/IRS, and US being 65, 45, 44, 55, and 45 %, respectively. Further 293 
details of the strain 1976 sequence, including an annotation of predicted protein-coding 294 
content (see below), are available in the GenBank accession. Four partial sequences from 295 
strain 1976 have been published previously, and all are identical to the corresponding sections 296 
of the genome sequence. These include 8667 bp extending from within UL40 to within UL36 297 
(GenBank accession AY338245), and much shorter sequences from UL39 (DQ343900), UL5 298 
(DQ343892), and UL30 (DQ343881) (6). 299 
In alphaherpesvirus genomes, unique regions flanked by inverted repeats are typically 300 
present in either orientation in virion DNA, giving rise to the presence of more than one 301 
genome isomer (2). Consequently, the orientations of UT and US in the strain 1976 genome 302 
were investigated by Southern blot analysis (Fig. 3). Fig. 3A illustrates the four possible 303 
arrangements of UT-UL and UL-US, and the restriction endonuclease fragments potentially 304 
generated by digestion with EcoRI or KpnI. Hybridizations performed with appropriate 305 
probes showed that UT and US are present in either orientation, whereas UL, which is not 306 
flanked by an inverted repeat, is present in a single orientation (Fig. 3B). These results 307 
indicate that TeHV-3 virion populations contain a mixture of four genome isomers differing 308 
in the relative orientations of UT and US. 309 
Genome sequence of strain 4295 310 
The filtered data set for strain 4295 consisted of 9,772,400 reads, of which 3,106,488 311 
(32%) aligned with the finished sequence at an average coverage of 5195 reads/nt. Analysis of 312 
the data indicated that the DNA contained a mixture of three related genome populations, 313 
each most simply interpreted as being a deleted form of a genome similar to that of strain 314 
1976. The extents of the deletions in relation to strain 1976 are marked by horizontal green 315 
bars in Fig. 2. The three genome forms were named m1 and m2 (the minor forms, estimated 316 
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from counting reads representing the novel junction, representing approximately 23 and 11 % 317 
of the population, respectively), and M (the major form representing approximately 66 % of 318 
the population). This interpretation was confirmed by subcloning the m1, m2, and M forms by 319 
limiting dilution and sequencing their genomes at an average coverage of 25, 46, and 22 320 
reads/nt, respectively. Compared with the strain 1976 sequence, the m1, m2, and M forms 321 
exhibit large, partially overlapping deletions of 22,424, 12,485, and 18,315 bp, respectively, 322 
extending from UT (in the orientation shown in Fig. 2), across IRT, to UL. No reads matching 323 
the region in the strain 1976 genome that corresponds to the region absent from all three 324 
forms (nt 4780-14989 in strain 1976) were detected in strain 4295 prior to subcloning, 325 
indicating that none of putative parental genome remained. In addition, the data supported the 326 
presence of two sizeable duplications in strain 4295 prior to subcloning and in the subclones, 327 
one located near the right end of UL (present in the m1 and m2 forms) and the other in IRS and 328 
TRS (present in all three forms). The extents of these duplications relative to strain 1976 are 329 
marked by horizontal orange bars in Fig. 2. Further details of the sequences of the strain 4295 330 
subclones, including annotations of coding content, are available in the GenBank accessions. 331 
No reads diagnostic of the deletions and duplications in strain 4295 (i.e., reads representing 332 
the novel junctions) were detected in strain 1976. The genomes of strain 1976 and 4295 (the 333 
M form) are closely related, differing by 193 substitutions (including IRS but not TRS, and not 334 
counting insertions or deletions). 335 
General features of the TeHV-3 genome 336 
Standard bioinformatic approaches were taken to predict the locations of open reading 337 
frames (ORFs) in the strain 1976 genome that encode functional proteins (for example, see 338 
(30)). In general, ORFs were included that potentially encode proteins of 100 or more amino 339 
acid residues, that do not extensively overlap ORFs predicted to be functional (i.e., ORFs 340 
encoding proteins that are similar to proteins of known function or have features suggesting 341 
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function, such as hydrophobic domains), and that are located appropriately in relation to 342 
potential mRNA polyadenylation signals. Particular attention was paid to ORFs that have 343 
counterparts in other herpesviruses. Four ORFs potentially encoding proteins of fewer than 344 
100 residues were also added because they are related to recognized herpesvirus proteins 345 
(UL11) or have other distinguishable features (TE35, TE36, and TE39). Splicing was 346 
predicted in five ORFs (TE12, TE13, ORF13, UL15, and TE25). The first ATG in each ORF 347 
was assigned as the initiation codon, except in cases in which use of a subsequent ATG was 348 
supported by alignments with related proteins or in which it provided a putative signal 349 
peptide. 350 
The analysis indicated that the strain 1976 genome encodes a total of 107 predicted 351 
functional ORFs (Fig. 2 and Table 2), three of which are duplicated in the inverted repeats 352 
(TE1 in TRT/IRT, and TE25 and RS1 in TRS/IRS). These 107 ORFs are conserved in strain 353 
4295, except for those affected by the deletions, and TE35, which is frameshifted (and 354 
therefore considered marginal in strain 1976). A total of 19 ORFs belong to six families of 355 
paralogous genes: the TE3 family with nine members, and the TE15, TE22, TE27, UL55, and 356 
US3 families, each with two members. The genome also contains three copies of a potential 357 
origin of DNA replication (ori), identified as an A+T-rich region capable of forming a hairpin 358 
structure and containing characteristic sequence motifs involved in binding the UL9 DNA 359 
replication origin-binding helicase (52-54) (Fig. 2). Approximately 37 % of strain 1976 360 
genomes appear to contain a 154 bp deletion that results in the absence of one of the copies of 361 
ori from the region between UL1 and TE25. This deletion also appears to be present in 362 
approximately 50 % of strain 4295 genomes prior to subcloning, but their distribution in this 363 
strain and in subclones m1 and m2 was not determined with certainty because of the 364 
ambiguity caused by duplications in this region. 365 
 366 
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Relationships between TeHV-3 and other herpesviruses 367 
The strain 1976 ORFs are shown in three categories in Fig. 2, according to their 368 
conservation in other herpesviruses. The first category (shaded red) consists of the 44 genes 369 
that are thought to have been inherited from the ancestor of the alpha-, beta-, and 370 
gammaherpesviruses. The second category (shaded blue) comprises the 21 additional ORFs 371 
(not counting duplicates) that have orthologs in alphaherpesviruses of mammals or birds. The 372 
third category (shaded orange) contains the remaining 42 ORFs (TE1-TE42), all of which 373 
lack counterparts in other herpesviruses, except for TE31, which has an orthologue in the 374 
turtle alphaherpesvirus ChHV-5 (4). This category of TeHV-3-specific gene includes the TE3, 375 
TE15, TE22, and TE27 families, as well as genes TE7, TE8, and TE11, which are similar to 376 
SEMAs, IL-10s, and C-type lectins, respectively. 377 
The full list of TeHV-3 strain 1976 ORFs is provided in Table 2, including those 378 
having counterparts in ChHV-5 (marked with asterisks in the first column). The order of 379 
conserved ORFs in the TeHV-3 genome is the same as that in ChHV-5, except for the absence 380 
or disruption of 14 ORFs in the latter (UL44-UL51, UL54, UL39, UL40, and UL13) and the 381 
inversion of UL55 (of which TeHV-3 has two counterparts, UL55A and UL55B). 382 
Comparison with other alphaherpesvirus lineages (in the mammalian alphaherpesvirus genera 383 
Simplexvirus and Varicellovirus, and the avian alphaherpesvirus genera Mardivirus and 384 
Iltovirus) (55) indicates that the ancestral alphaherpesvirus contained conserved ORFs 385 
arranged in the same order as in TeHV-3 from UL43 rightwards. The ancestral state from 386 
UL54 leftwards is more difficult to discern, as this region appears to have undergone 387 
rearrangements in various lineages. 388 
Phylogenetic analysis of short regions of the genome has indicated previously that 389 
TeHV-3 is an alphaherpesvirus (6). This conclusion is supported from the complete genome 390 
sequence by the presence in TeHV-3 of 21 ORFs that have orthologs in alphaherpesviruses 391 
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but not in beta- or gammaherpesviruses (Fig. 2), and by phylogenetic analysis of the DNA 392 
polymerase (Fig. 4A). This analysis also indicates that the closest known relative of TeHV-3 393 
is ChHV-5, the current sole member of the genus Scutavirus (1). However, despite their 394 
relationship, the two viruses do not share the same genome structure, ChHV-5 apparently 395 
adopting the simpler UL-IRS-US-TRS arrangement (4). Given the relatively large phylogenetic 396 
distance between TeHV-3 and ChHV-5, it is a matter of judgment whether TeHV-3 should be 397 
classified as a new species into the same genus as ChHV-5 or into a new genus. Since these 398 
are the only relevant viruses that have been examined in sufficient detail, and both infect 399 
Testudines, we recommend the former as the safer option. Regardless of the eventual 400 
taxonomical outcome, the results establish a robust phylogenetic relationship between tortoise 401 
and turtle herpesviruses. 402 
Phylogenic analysis and homology modelling of the TeHV-3 TE7 and TE8 proteins 403 
The finding that the TeHV-3 TE7 and TE8 genes encode SEMA and IL-10 homologs, 404 
respectively, is particularly interesting for the following reasons. First, SEMA homologs have 405 
been reported in the family Herpesviridae only in the Macavirus genus of subfamily 406 
Gammaherpesvirinae (56). Second, although numerous IL-10 homologs have been described 407 
in the subfamilies Betaherpesvirinae and Gammaherpesvirinae (42), they have not been 408 
reported in the subfamily Alphaherpesvirinae. We performed phylogenetic analyses to 409 
determine whether the origins of the TeHV-3 SEMA and IL-10 homologs could be traced. We 410 
also performed homology modelling analyses, in order to assess whether these viral genes 411 
encode functional homologs of the cellular genes. 412 
A maximum likelihood phylogenetic tree placed the TeHV-3 SEMA (the TE7 protein) 413 
as the nearest neighbor to a cluster of poxvirus SEMAs, with low bootstrap confidence (Fig. 414 
4B). No viral SEMA is close enough to any cellular counterpart to justify the deduction of an 415 
evolutionary scenario involving a recent gene transfer from host to virus. In contrast, as 416 
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previously described (42), some viral IL-10s (in HHV-4, EHV-2, and ORFV) cluster 417 
phylogenetically with cellular IL-10s, implying relatively recent gene transfers and a degree 418 
of functional conservation (Fig. 4C). However, other viral IL-10s (including that of TeHV-3) 419 
are more divergent from host IL-10s, implying earlier gene transfer events with subsequent 420 
genetic drift and possible functional divergence. As a consequence, no inference concerning 421 
the evolutionary history of the TeHV-3 IL-10 (the TE8 protein) can be made, other than the 422 
speculation that it originated from a host in a relatively ancient transfer event, as appears to be 423 
the case for many other viral IL-10s (42). 424 
We investigated the possibility of functional divergence by using homology modelling 425 
of the TE7 and TE8 proteins in comparison with cellular SEMAs and IL-10s, respectively 426 
(Fig. 5 and 6). The templates were selected for superposition on the basis of the lowest root 427 
mean square deviation (RMSD) values exhibited by the top BLAST hits. This process 428 
indicated that mouse SEMA-3A and human IL-10 were the best templates (Table A1). It 429 
should not be inferred from these choices that we believe the TE7 protein to be an ortholog of 430 
mouse SEMA-3A or the TE8 protein an ortholog of human IL-10. Indeed, the top BLAST hit 431 
of the TE7 protein among the cellular SEMAs was SEMA-7A; hence the use of this group of 432 
proteins in Fig. 4B. On the basis of the templates selected, modelling clearly demonstrates 433 
that the TE7 protein (Fig. 5B) and the TE8 protein (Fig. 6B) are both capable of assuming 434 
backbone structures highly similar to their cellular counterparts, despite having a high degree 435 
of sequence divergence. Both TE7 and TE8 homology models contain some residues that are 436 
sub-optimal in terms of their stereochemistry (Fig. 5C and 6C).  However, these are mostly at 437 
turns in the backbone or loop regions (Fig. 5B and 6B).  Major secondary structural regions, 438 
by contrast, are well formed in terms of their stereochemistry. We conclude that functional 439 
divergence is unlikely to have occurred to an extent such that these two viral proteins no 440 
longer operate in ways analogous to their cellular equivalents, and therefore that the TE7 and 441 
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TE8 proteins are likely to have maintained SEMA and IL-10 functions. This conclusion is 442 
further supported by key residues of TE7 and TE8 proteins. The three-dimensional structure 443 
of SEMA-7A bound to its receptor PLEXIN-C1 has been resolved, and key residues in the 444 
SEMA sequence for the interaction with its receptor have been identified (57). Interestingly, 445 
most of these residues present in the blade 3, 4c-4d loop, and extrusion helix 2 regions were 446 
conserved in TE7. Among the residues conserved in TeHV-3, only one of them (Ile238) had a 447 
sub-optimal stereochemistry (Fig. 5B). Together, these data suggested that the TeHV-3 TE7 448 
protein might also signal through PLEXIN-C1 and function similarly to other viral SEMAs 449 
(56). As for the TE8 protein, its sequence exhibits most of the residues found in the two 450 
family signature motifs characteristic of all cellular Il-10s: L-[FILMV]-X3-[ILV]-X3-451 
[FILMV]-X5-C-X5-[ILMV]-[ILMV]-X(3)-L-X2-[IV]-[FILMV] and KA-X2-E-X-D-[ILV]-452 
[FLY]-[FILMV]-X2-[ILMV]-[EKQZ] (residues that are not conserved in the TE8 protein are 453 
underlined). 454 
Requirement in vitro of the genome regions deleted in the three forms of strain 4295 455 
The m1, m2, and M forms of strain 4295 exhibit partially overlapping deletions in 456 
their genomes (Fig. 2). The observation that all three forms lack the region corresponding to 457 
coordinates 4780-14989 in strain 1976 indicates that this 10,210 bp sequence is not essential 458 
for viral replication in vitro. As the three forms resulted from a co-culture, it is possible that 459 
each of them requires complementation by the others in order to provide the functions that 460 
have been lost. To test this hypothesis, strain 4295 was subcloned by limiting dilution, and the 461 
subclones were analyzed by PCR (Fig. 7A, B). This experiment demonstrated that the three 462 
forms are capable of growing in vitro, despite relatively large deletions. To determine whether 463 
the deletions have quantitative effects on viral growth, the three subclones were compared 464 
using a multi-step growth assay. They replicated comparably with each other and strain 1976, 465 
thereby demonstrating that none of the deleted genes affected viral replication in the assay 466 
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used (Fig. 7C). Finally, the morphogenic properties of strains 1976 and 4295 were compared 467 
by electron microscopic examination of infected TH-1 cells (Fig. 1). In a blind test, it was not 468 
possible to differentiate the two strains, both of which exhibited all the features typical of 469 
TeHV-3 and herpesviruses in general. 470 
Pathogenesis of strain 4295 471 
The tortoises that are most sensitive to TeHV-3 infection belong to the genus Testudo 472 
(58). All species in this genus are protected by the Convention on International Trade in 473 
Endangered Species of wild fauna and flora (CITES). Consequently, their use in in vivo 474 
experiments is highly restricted and, moreover, carries the mandatory condition that the 475 
scientific objective of any such experiments must contribute to species conservation. As 476 
indicated above, no safe and efficacious vaccine is yet available against TeHV-3. The 477 
observation that strain 4295 consists of a mixture of three deletion mutants prompted us to test 478 
the potential of this mixture as an attenuated vaccine. With this goal in mind, three tortoises 479 
were inoculated with strain 4295 (the same passage that the one used for sequencing and 480 
which was shown to be a mixture of the m1, m2 and M forms) by intranasal instillation, and 481 
one sentinel tortoise was mock-infected (Fig. 8). Our intention was to observe the animals for 482 
2 months, in order to assess the safety of the inoculated material, and then to challenge them 483 
with strain 1976 and evaluate the immune protection conferred. However, all three infected 484 
tortoises became apathetic at about 20 days post-inoculation (PI), and then reduced feeding 485 
progressively, to become anorexic between 22 and 29 days PI. Significant nasal discharge was 486 
observed by 30 to 37 days PI, with mild blepharoedema. Diphtheritic plaques were observed 487 
in the buccal cavity of one tortoise (4295/41 D). The animals were euthanized at 38 and 41 488 
days PI due to extreme weakness (defined as one of the endpoints by the local ethics 489 
committee). The mock-infected tortoise did not show any symptoms throughout the course of 490 
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the experiment. It was euthanized at 75 days PI in order to serve as a negative control for 491 
further analyses (see below). 492 
At necropsy, few macroscopic lesions were observed. A single tortoise (4295/41 D) 493 
exhibited diphtheritic membranes on the buccal and esophageal mucosa. No other lesions 494 
were observed in the infected tortoises or the mock-infected tortoise. Histopathological 495 
analysis of various organs (lung, spleen, brain, kidney, and liver) of the infected tortoises 496 
revealed mild lesions consistent with previous reports (8, 13) (Fig. 9). These lesions consisted 497 
of interstitial heterophilic infiltration of the lung, congestion and heterophilic infiltration of 498 
the red pulp of the spleen, and glial cell infiltration of the brain (telencephalon). The kidney 499 
and the liver did not show significant histopathological modifications. Eosinophilic 500 
intranuclear inclusion bodies were not detected in any of the samples examined. 501 
To investigate tissue tropism, viral load was estimated in various organs (lung, spleen, 502 
brain, kidney, and liver) using a qPCR method developed for the purpose. Consistent with 503 
earlier reports (8, 13, 16) , the virus was detected in all organs tested (Fig. 10A). However, in 504 
all three infected tortoises, the highest viral load was detected in the brain (p<0.05), slightly 505 
greater than the viral load in the spleen. The other organs revealed lower and comparable viral 506 
loads (p<0.01). At three week intervals, peripheral mononuclear blood cells were collected 507 
during the entire course of the experiment and subjected to qPCR analyses. TeHV-3 was not 508 
detected in any of the samples (data not shown). 509 
Finally, we used the PCR assays described above to determine whether the viral load 510 
detected in the various organs in Fig. 10A represented all three forms of 4295 (Fig. 10B). The 511 
m1 form was not detected in any sample. The m2 form was detected with the highest 512 
frequency, and was identified in all organs shown to be positive for TeHV-3 by PCR of a 513 
gene present in all forms (UL13). Like the m2 form, the M form was detected in the brain of 514 
all infected subjects. However, its presence in the other organs was reduced compared to the 515 
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m2 form. The M form was detected in only a fraction of the lungs and the spleens positive for 516 
the m2 form, and, with exception of one sample, it was not detected in the kidney and liver 517 
samples that were positive for the m2 form. 518 
As the PCR data presented above were derived from tortoises that had been 519 
co-infected with a mixture of the three forms present in strain 4295, they should be interpreted 520 
cautiously in terms of the fitness of individual forms. Indeed, even if it might be viewed as 521 
unlikely, in vivo interactions between the forms, such as helper effects resulting from 522 
superinfection of the same host cells or secretion of soluble factors, cannot be excluded. 523 
Consequently, the conclusions described below will need to be confirmed by experimental 524 
infection of animals by the individual genotypes. The ability of the m2 form to spread 525 
throughout the body suggests that the region of the TeHV-3 genome encompassing genes TE3 526 
to TE11 (corresponding to the deletion in this form) is not essential for virulence and 527 
neuroinvasiveness. Similarly, the ability of the M form to invade the brain suggests that the 528 
region encoding genes TE4 to TE16 is not essential for neuroinvasiveness. However, 529 
compared to the m2 form, the restricted tropism of the M form for the other organs suggests 530 
that one or more genes in the region containing genes TE12 to TE16 may contribute to viral 531 
spread in vivo.   532 
Setting aside any possible interactions that may have occurred between the three forms 533 
in vivo, the results of the analyses presented in Fig. 10B suggest that the region encompassing 534 
TE4 to TE11 (the deletion common to all three forms), as well as not being required for viral 535 
growth in vitro, is not essential for virulence of TeHV-3 in vivo. Importantly, the inability of 536 
the m1 form to spread in vivo (despite co-infection with the two other genotypes) 537 
demonstrates that the region encompassing genes UL55B to TE19 contains one or more genes 538 
that are essential (alone or in combination) for viral spread in vivo. As the m1 form was 539 
shown to grow in vitro as efficiently as the two other forms (m2 and M) and strain 1976, the 540 
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results of the present study encourage the testing of the m1 subclone of strain 4295 as an 541 
attenuated vaccine candidate. While this study was under review, a version of the strain 1976 542 
genome sequence became available (59). In comparison with our sequence, this contains a 543 
9521 nt deletion (nt 5469-14989) starting in TE5 and ending near the left end of UL, and thus 544 
lacks seven genes, including TE7 and TE8. The similarity in location between this deletion 545 
and those in strain 4295 indicates that the TeHV-3 genome has a propensity for losing 546 
information in this region. Based on the pathogenic properties of strain 4295, we predict that 547 
the deletion in strain 1976 will not affect viral spread in vivo. However, the sequence also has 548 
frameshifts in TE19 that, if not due to error, may affect virulence, since this gene is absent 549 
from the m1 form of strain 4295. 550 
Our study reports the complete genome sequences of TeHV-3 strains 1976 and 4295, 551 
the latter comprising a mixture of three deletion mutants that were sequenced as the mixture 552 
and as subclones. The sequence of strain 1976 revealed a novel genome structure in the 553 
family Herpesviridae. Genetic analysis highlighted the presence of genes related to cellular 554 
genes (SEMA and IL-10) that have not been reported previously in alphaherpesviruses. 555 
Phylogenetic analysis showed that TeHV-3 is most closely related to turtle herpesviruses, and 556 
suggested the classification of this virus in the genus Scutavirus. Importantly, in vitro and in 557 
vivo analyses demonstrated that the TeHV-3 genome contains large regions that are essential 558 
neither for viral replication in vitro nor for virulence in vivo. They also indicated that spread 559 
of the m1 form of strain 4295 is attenuated in vivo, thus indicating that this form would be a 560 
good starting point for the development of vaccine candidates. In conclusion, the present 561 
study represents a major step towards the characterization of an important viral pathogen of 562 
tortoises and the development of effective prophylactic measures against TeHV-3 disease.563 
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FIGURE LEGENDS 737 
FIG 1 Morphology of TeHV-3. TH-1 cells were infected with strains 1976 and 4295. Six 738 
days post-infection, cells were processed for electron microscopy examination. In a blind test, 739 
it was not possible to differentiate the two strains. The images in this figure represent TH-1 740 
cells infected with strain 1976. (A) General view of the various compartments of an infected 741 
cell. (B) Nucleoplasm. (C) Nucleus and cytoplasm. (D) Cytoplasm and extracellular space. 742 
FIG 2 Map of the TeHV-3 strain 1976 genome. The unique regions (UT, UL, and US) are 743 
shaded white, and the inverted repeats (TRT, IRT, IRS, and TRS) are shaded light yellow. 744 
Predicted functional ORFs are depicted by colored arrows, with nomenclature below. Red 745 
shading indicates ORFs inherited from the ancestor of the alpha-, beta-, and 746 
gammaherpesviruses. Blue shading indicates ORFs that have orthologs in mammalian or 747 
avian alphaherpesviruses. Light orange shading indicates the remaining ORFs. Introns are 748 
shown as narrow white bars. Reiterations are shown by grey shading within or between ORFs, 749 
and three copies of ori by vertical, red bars. The deletions and the duplications present in the 750 
m1, m2, and M forms of TeHV-3 strain 4295 are marked above the genome by horizontal 751 
green and orange bars, respectively. 752 
FIG 3 Relative orientations of unique regions in the TeHV-3 strain 1976 genome. (A) A 753 
schematic representation of the genome is shown at the top, the orientations of UT, UL, and US 754 
corresponding to those in Fig. 2. Below this, the four possible combinations of the 755 
orientations of UT-UL and UL-US are presented, with the majority of UL omitted. For each 756 
combination, the sizes (kb) of restriction endonuclease fragments at or near the genome ends 757 
or the UT-UL and UL-US junctions are shown (EcoRI above the genome and KpnI below). 758 
White bars (P1 to P6) represent the positions of the probes used for hybridization. Asterisks 759 
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highlight restriction endonuclease fragments for which a positive band was observed in 760 
Southern blot analyses. (B) The panels on the right show a Southern blot analysis of TeHV-3 761 
strain 1976 DNA digested with EcoRI or KpnI and hybridized to probes P1 to P6. Black 762 
arrowheads indicate all bands compatible with the predicted fragments. The panel on the left 763 
shows an ethidium bromide-stained profile of marker fragments (MS) and strain 1976 DNA 764 
digested with EcoRI or KpnI. The 0.65 and 0.72 kb fragments were detected, but are not 765 
visible on these images, which have been restricted to fragments above 2 kb. 766 
FIG 4 Phylogenetic analyses. In each panel, the scale indicates substitutions per site. 767 
Abbreviations for herpesvirus names: El, elephantid; H, human; Mu, murid; E, equid; F, felid; 768 
Bo, bovid; S, suid; Ce, cercopithecine; Pt, pteropodid; Pn, panine; Mc, macacine; Pa, papiine; 769 
Sa, saimiriine; Ga, gallid; Me, meleagrid; Co, columbid; An, anatid; Ac, acciptrid; Ps, 770 
psittacid; Te, testudinid; Ch, chelonid; Ov, ovine; Al, alcelaphine; Cy, cyprinid; and HV, 771 
herpesvirus (followed by a hyphenated number). Other abbreviations: CNPV, canarypox 772 
virus; FPV, fowlpox virus; PEPV, penguin poxvirus; PNPV, pigeon poxvirus; SGIV, 773 
Singapore grouper iridovirus; VARV, variola virus; HSPV, horse poxvirus; VACV, vaccinia 774 
virus; ECTV, ectromelia virus; CPXV, cowpox virus; RPXV, rabbit poxvirus; ORFV, ORF 775 
virus; and SWPV, swinepox virus. (A) Bayesian tree for herpesvirus DNA polymerase 776 
proteins. All nodes have posterior probabilities of 1. Viruses that have not yet been classified 777 
are marked by asterisks (1). (B) Maximum likelihood tree for vertebrate SEMA-7A proteins 778 
and their viral homologs. Node bootstrap values greater than 70 are marked. (C) Maximum 779 
likelihood tree for IL-10 homologues. Node bootstrap values greater than 70 are marked. 780 
FIG 5 Homology model of the TeHV-3 SEMA (TE7) protein. (A) Mouse SEMA-3A PDB 781 
1Q47. (B) Homology model of TeHV-3 TE7 constructed from 1Q47 with sub-optimal 782 
residues shown. (C)  Ramachandran plot of homology model used to identify sub-optimal 783 
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residues. (D) Mouse SEMA-3A PDB 1Q47 (blue) superposed with the homology model of 784 
TeHV-3 TE7 (red).  785 
FIG 6 Homology model of the TeHV-3 IL-10 (TE8) protein. (A) Human IL-10 PDB 1ILK. 786 
(B) Homology model of TeHV-3 IL-10 constructed from 1ILK with sub-optimal residues 787 
shown. (C) Ramachandran plot of homology model used to identify sub-optimal residues. (D) 788 
Human IL-10 PDB 1ILK (blue) superposed with the homology model of TeHV-3 IL-10 (red).  789 
FIG 7 Effects of the deletions in the m1, m2 and M forms of strain 4295 on viral growth in 790 
vitro. (A) Schematic representation of the regions in the strain 1976 genome corresponding to 791 
the deletions in the three forms of strain 4295, with the coordinates of the deletions indicated 792 
above the strain 1976 genome. Arrows represent primers (Table 1) designed for PCR 793 
amplification of the regions containing the deletions. Amplicon sizes are indicated in bold 794 
below the genomes of the strain 4295 subclones. PCR amplification performed with the 795 
UL13f and UL13r primers led to a product of 106 bp (B) Characterization by PCR of the 796 
strain 4295 subclones representing the three genome forms. Strain 4295 prior to subcloning 797 
(containing the three forms) and strain 1976 were used as controls. The positions of markers 798 
(bp) are marked by arrowheads. (C) Multi-step growth curves of the strain 4295 subclones 799 
and strain 1976. 800 
FIG 8 Pathogenesis of strain 4295. On day 0, tortoises (n=4) aged 5.4 years (mean weight ± 801 
SD: 219.5 g ± 53.1 g) were infected (n=3) with strain 4295 (consisting of a mixture of three 802 
deletion mutants) or mock-infected (n=1). Percentage survival is expressed according to days 803 
PI. The tortoises were named according to the following scheme: the inoculation performed 804 
(4295 or mock)/the time PI at which death occurred (when more than one tortoise died on the 805 
same day, they were further ranked by the addition of a lower case letter), and an upper case 806 
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letter to describe the clinical state before euthanasia (D, diseased; H, healthy). 807 
FIG 9 Histopathological characterization of the lesions induced by strain 4295 (consisting of 808 
a mixture of three deletion mutants). The indicated organs were collected from all tortoises at 809 
the end of the experiment described in Fig. 8, and were processed for histological 810 
examination. The images were collected from tortoises Mock/75 H and 4295/41 D, the latter 811 
having been selected as representative of the infected group. H, heterophil; F, faveolae; GC, 812 
glial cell; C, capillary; PT, proximal tubule; DT, distal tubule; G, glomerulus; S, sinusoid; and 813 
M, melanomacrophage. Bars = 20 µm. 814 
FIG 10 Tissue tropism of strain 4295. DNA was extracted from the indicated organs of all 815 
tortoises at the end of the experiment described in Fig. 8. (A) Analysis of viral gene copy 816 
number by qPCR. Individual values represent the mean of triplicate measurements ± SD. (B) 817 
Analysis of the presence of the three forms present in strain 4295, using primers specific for 818 
each form (m1, m2, and M) and all three forms (UL13). See Fig. 7B and Table 1 for details of 819 
the primers. Strain 4295 (containing the three forms) was used as positive (CT) control. 820 
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TABLE 1 Oligonucleotide primers. 
 
Description Primer name Sequence (5’-3’) Coordinatesa 
For synthesis of probes for Southern blot analysis (probe name) 
P1 TE2 F ATACAGTCCGTGGGATCCAG 1303 - 1322 TE2 R CACGTGAGGCACATAGGAGA 1516 - 1535 
P2 TE11 F CAGAGGCTGAAGGAAACTGG 13285 - 13304 TE11 R TCCTCCCGCTATAGGAAACC 13477 - 13496 
P3 TE12 F AAGCCTGGTGGTACGATGAC 15747 - 15766 TE12 R GCAATCTCCGATAAGCTCCA 15960 - 15979 
P4 UL1 F TTTCCCGTACCTCTGTCTCG 120587 - 120606 UL1 R ATGAGATGTTGCTGCGACTG 120960 - 120979 
P5 TE28 F ATAGCGGCCGACAATGTAAC 134019 - 134038 TE28 R TGGCCCGAAGTATTTTTACG 134176 - 134195 
P6 TE42 F GTCTCGGTCCATGGCTATTC 151441 - 151460 TE42 R TCAGGGAGTAGTGGGTGGAG 151666 - 151685 
 
For qPCR analysis (gene amplified) 
TeHV-3 UL13 UL13 F CGCATCCGTCAGGAATCTAT 103686 - 103705 UL13 R GGTCCCTCGTCCAACTAACA 103772 - 103791 
T. hermanni β-actin geneb Beta-actin F TCTGGTCGTACCACAGGTATTG Not applicable Beta-actin R AGATCCAGACGGAGGATGG Not applicable 
 
For analyzing specific features in the strain 1976 and strain 4295 genomes (targeted feature)c 
Reiteration at 6540-6842 TE5 F AATACATGATACCAATCCCAGTTG 6473 - 6496 TE5 R CCAGAGGGGACACCGCAGATGACA 6902 - 6925 
Reiteration at 27611-28227 TE19/1 F ACTCCTGGCCACAGAACCAGTTGG 27559 - 27582 TE19/1 R TAAAAACATACCAGGAGGTTCCCA 28251 - 28274 
Reiteration at 31883-32067 ORF13 F ATCCAATACATATTTCACGG 31818 - 31837 ORF13 R CTGGTTCGAAACCTACGTATCGAG 32122 - 32145 
Reiteration at 59762-59971 UL36 F GTTGTTTACCCAGTTCCTGTACCA 59684 - 59707 UL36 R CATCTGGAAATAGTGTTGGCTATC 60040 - 60063 
Reiteration at 97095-97300 TE22-TE23 F CAAACGGCCATATCTCTTAG 97032 - 97051 TE22-TE23 R TAGAGCTCTGATCAATGTGTATAC 97387 - 97410 
Reiteration at 121235-121565 UL1-IRS/1 F TTTACAAAGCCGGGTGGAGCCTGG 121132 - 121155 UL1-IRS/1 R AGTCCCGGCATCGGCCGTGGTGGA 121629 - 121652 
Duplication at 121745-121964 
(ori) 
UL1-IRS/2 F TACAAGTACCTGATCGGGCT 121682 - 121701 
UL1-IRS/2 R CCGAGATTTGGTACGGCTAGGACC 122396 - 122419 
Reiteration at 126971-127795 
and 151910-152308 
TE25-RS1 F ACGATTACGATGAGAGCACTGACA 126811 - 126834 
TE25-RS1 R AGAACTGACCGGATTGGTGAACGA 127965 - 127988 
Reiteration at 130962-131360 
and 155475-156299 
RS1-US F GACCAGGCAGGTGCTTCATCCGTA 130866 - 130889 
RS1-US R CTCCTAGCATTCCCATTGGC 131378 – 131397 d 
Reiteration at 131398-131576 RS1-TE26 F GTCATGTCAACCAGCCAATG 131365 - 131384 RS1-TE26 R TTCATGAGGGTCACACTGAC 131607 - 131626 
Reiteration at 150542-150717 TE42/1 F TTCTGATATCCTGGGGACAT 150461 - 150480 TE42/1 R ATAGTAGTGTTGATTCGTCC 150754 - 150773 
Reiteration at 151008-151141 TE42/2 F AGAGGTCGCTGCTCTCTTAACTGA 150907 - 150930 TE42/2 R TAGAGGTAGAGGCTACGCCAGGTC 151370 - 151393 
Duplication in RS1 
(strain 4295)d 
RS1 M F ACGACATCTGCTATCTCAGTGCAC 129099 - 129122 
RS1 M R TATACCAGGCTTTCGATGCGCTGG 130014 - 130038 
Left genome terminus LEFT TERMINUS R GCGAATCCGCAGGCAATCGCAACA 205 - 228 
Left genome terminuse LEFT TERMINUS F GCGATCCAAATACGCGTAGCGATT 122704 - 122727 
Right genome terminus RIGHT TERMINUS F ACCCTCCGAAGAGCAGACCATGAG 160211 – 160234 
 
For genotyping strain 4295 forms (targeted form or gene) 
M TE4/1 F GATGGGTATGGAACGTCACC 3790 - 3809 TE16 R CGGCCATGGTTAGAAAAAGA 22567 - 22586 
m1 TE4/2 F CAATCATCTGAGCGTTGGAA 4534 - 4553 TE19/2 R ATTCGTCCGTCACAGTAGGG 27514 - 27533 
m2 TE3 F AAAGTCCGCTCCTCTCATCA 2281 - 2300 up TE12 R GCCGCCTAATAGGTTCTTTG 15221 - 15240 
TE8 TE8 F CGAGCAGCCTAATTCAGACC 10046 - 10065 TE8 R AACGCCTTTCTGAACGAAGA 10236 - 10255 
 
 
a Coordinates are listed in relation to the strain 1976 genome. 
b Amplified fragment (primers omitted): 5’-TCT GGT CGT ACC ACA GGT ATT GTG 
ATG GAC TCT GGT GAT GGT GTC ACC CAC ACT GTG CCC ATC TAT GAA GGT 
TAT GCC CTC CCC CAC GCC ATC CTC CGT CTG GAT CT-3’ 
c Principal primers only. Additional primers were used to generate confirmatory PCR 
products or sequence them. An adapter-specific primer was used in combination with 
virus-specific primers to locate the genome termini. 
d Present in strain 4295 only. Coordinates correspond to the strain 1976 genome. 
e UL is inverted in a proportion of strain 4295 genomes. 
  
  
TABLE 2 Features of predicted functional protein-coding regions in the TeHV-3 strain 1976 genome. 
 
Gene 
namea 
Gene 
family 
Protein size 
(residues) Protein name
b Protein features 
TE1  207 Protein TE1  
TE2  152 Protein TE2  
TE3 TE3 505 Protein TE3 Contains signal peptide 
TE4 TE3 520 Protein TE4 Contains signal peptide 
TE5 TE3 774 Protein TE5 Contains signal peptide
TE6  106 Protein TE6 Contains potential transmembrane domain 
TE7  653 Semaphorin Type 1 membrane protein 
TE8  168 Interleukin-10 Contains signal peptide 
TE9 TE3 473 Membrane protein TE9 Type 1 membrane protein 
TE10  210 Protein TE10  
TE11  200 Protein TE11 Contains potential transmembrane domain; similar to C-type lectins 
TE1  207 Protein TE1  
TE12 TE3 658 Protein TE12 Contains signal peptide 
TE13 TE3 636 Protein TE13 Contains signal peptide 
TE14  162 Protein TE14 
TE15 TE15 231 Protein TE15  
UL55A UL55 218 Nuclear protein UL55A  
TE16 TE15 229 Protein TE16  
UL55B* UL55 221 Nuclear protein UL55B  
TE17  432 Protein TE17 
TE18  525 Protein TE18  
TE19  876 Membrane protein TE19 Type 1 membrane protein; contains immunoglobulin domains 
TE20  262 Membrane protein TE20 Type 1 membrane protein; contains immunoglobulin domain 
UL44  350 Envelope glycoprotein C Type 1 membrane protein; binds cell surface heparan sulphate; 
binds complement C3b to block neutralization; involved in cell 
attachment 
ORF13  302 Thymidylate synthase Involved in nucleotide metabolism 
UL45  146 Membrane protein UL45 Type 2 membrane protein; tegument-associated; possibly involved 
in membrane fusion 
TE21  100 Protein TE21 Contains potential transmembrane domain 
UL46  403 Tegument protein VP11/12 Modulates transactivating tegument protein VP16; possibly involved 
in gene regulation 
UL47  473 Tegument protein VP13/14 Modulates transactivating tegument protein VP16; RNA-binding 
protein; possibly involved in gene regulation 
UL48  428 Transactivating tegument protein 
VP16 
Transactivates immediate early genes; involved in gene regulation; 
involved in virion morphogenesis 
UL49  212 Tegument protein VP22 Involved in virion morphogenesis; possibly involved in RNA 
transport to uninfected cells 
UL49A  100 Envelope glycoprotein N Type 1 membrane protein; complexed with envelope glycoprotein 
M; involved in virion morphogenesis; involved in membrane fusion 
UL50  447 Deoxyuridine triphosphatase Involved in nucleotide metabolism 
UL51  216 Tegument protein UL51 Involved in virion morphogenesis 
UL52*  906 Helicase-primase primase subunit Involved in DNA replication 
UL53*  346 Envelope glycoprotein K Type 3 membrane protein; 4 transmembrane domains; involved in 
virion morphogenesis; involved in membrane fusion 
ORFG*  201 Protein IG Contains a possible zinc-binding domain 
UL54  953 Multifunctional expression regulator RNA-binding protein; shuttles between nucleus and cytoplasm; 
inhibits pre-mRNA splicing; exports virus mRNA from nucleus; 
exerts most effects post-transcriptionally; involved in gene 
regulation; involved in RNA metabolism and transport 
UL43*  396 Envelope protein UL43 Type 3 membrane protein; possibly involved in membrane fusion 
UL42*  368 DNA polymerase processivity 
subunit 
dsDNA-binding protein; involved in DNA replication 
UL41*  319 Tegument host shutoff protein mRNA-specific RNase; involved in cellular mRNA degradation 
UL40  304 Ribonucleotide reductase subunit 2 Involved in nucleotide metabolism 
UL39  796 Ribonucleotide reductase subunit 1 Involved in nucleotide metabolism 
UL38*  447 Capsid triplex subunit 1 Complexed 1:2 with capsid triplex subunit 2 to connect capsid 
hexons and pentons; involved in capsid morphogenesis 
UL37*  1056 Tegument protein UL37 Complexed with large tegument protein; involved in virion 
morphogenesis 
UL36*  2619 Large tegument protein Complexed with tegument protein UL37; ubiquitin-specific protease 
(N-terminal region); involved in capsid transport 
UL35*  114 Small capsid protein Located externally on capsid hexons; involved in capsid 
morphogenesis; possibly involved in capsid transport 
UL34*  242 Nuclear egress membrane protein Type 2 membrane protein; interacts with nuclear egress lamina 
protein; involved in nuclear egress 
UL33*  115 DNA packaging protein UL33 Interacts with DNA packaging terminase subunit 2; involved in 
DNA encapsidation 
UL32*  537 DNA packaging protein UL32 Involved in DNA encapsidation; possibly involved in capsid 
transport 
UL31*  295 Nuclear egress lamina protein Interacts with nuclear egress membrane protein; involved in nuclear 
egress 
UL30*  1132 DNA polymerase catalytic subunit Involved in DNA replication 
UL29*  1183 Single-stranded DNA-binding 
protein 
Contains a zinc-finger; involved in DNA replication; possibly 
involved in gene regulation 
UL28*  730 DNA packaging terminase subunit 2 Involved in DNA encapsidation 
UL27*  827 Envelope glycoprotein B Type 1 membrane protein; possible membrane fusogen; binds cell 
surface heparan sulphate; involved in cell entry; involved in cell-to-
cell spread 
UL26.5*  233 Capsid scaffold protein Clipped near C terminus; involved in capsid morphogenesis 
UL26*  490 Capsid maturation protease Serine protease (N-terminal region); minor scaffold protein 
(remainder of protein, clipped near C terminus); involved in capsid 
morphogenesis
UL25*  575 DNA packaging tegument protein 
UL25 
Located on capsid near vertices; possibly stabilizes the capsid and 
retains the genome; involved in DNA encapsidation 
UL24*  324 Nuclear protein UL24  
UL23*  355 Thymidine kinase Involved in nucleotide metabolism 
UL22*  733 Envelope glycoprotein H Type 1 membrane protein; possible membrane fusogen; complexed 
with envelope glycoprotein L; involved in cell entry; involved in 
cell-to-cell spread 
UL21*  450 Tegument protein UL21 Interacts with microtubules; involved in virion morphogenesis 
UL20*  196 Envelope protein UL20 Type 3 membrane protein; 4 transmembrane domains; involved in 
virion morphogenesis; involved in membrane fusion
UL19*  1369 Major capsid protein 6 copies form hexons, 5 copies form pentons; involved in capsid 
morphogenesis 
UL18*  320 Capsid triplex subunit 2 Complexed 2:1 with capsid triplex subunit 1 to connect capsid 
hexons and pentons; involved in capsid morphogenesis 
TE22 TE22 153 Protein TE22  
TE23 TE22 150 Protein TE23  
UL15*  697 DNA packaging terminase subunit 1 Contains an ATPase domain; involved in DNA encapsidation 
UL17*  652 DNA packaging tegument protein 
UL17 
Capsid-associated; involved in DNA encapsidation; involved in 
capsid transport 
UL16*  335 Tegument protein UL16 Possibly involved in virion morphogenesis 
UL14*  177 Tegument protein UL14 Involved in virion morphogenesis 
UL13  437 Tegument serine/threonine protein 
kinase 
Involved in protein phosphorylation 
UL12*  533 Deoxyribonuclease Involved in DNA processing
UL11*  79 Myristylated tegument protein Envelope-associated; involved in virion morphogenesis 
UL10*  412 Envelope glycoprotein M Type 3 membrane protein; 8 transmembrane domains; complexed 
with envelope glycoprotein N; involved in virion morphogenesis; 
involved in membrane fusion 
UL9*  784 DNA replication origin-binding 
helicase 
Involved in DNA replication 
UL8*  716 Helicase-primase subunit Involved in DNA replication 
UL7*  271 Tegument protein UL7 Involved in virion morphogenesis 
UL6*  669 Capsid portal protein Dodecamer located at one capsid vertex in place of a penton; 
involved in DNA encapsidation 
UL5*  851 Helicase-primase helicase subunit Involved in DNA replication 
UL4*  227 Nuclear protein UL4 Colocalizes with regulatory protein ICP22 and nuclear protein UL3 
in small, dense nuclear bodies 
TE24  131 Protein TE24  
UL3*  193 Nuclear protein UL3 Colocalizes with regulatory protein ICP22 and nuclear protein UL4 
in small, dense nuclear bodies 
UL2*  270 Uracil-DNA glycosylase Involved in DNA repair 
UL1*  127 Envelope glycoprotein L Contains signal peptide; complexed with envelope glycoprotein H; 
involved in cell entry; involved in cell-to-cell spread 
TE25 TE3 953 Protein TE25 Contains signal peptide 
RS1*  965 Transcriptional regulator ICP4 Involved in gene regulation 
TE26  210 Protein TE26  
TE27 TE27 241 Protein TE27 Contains potential transmembrane domain 
TE28  246 Protein TE28 Contains potential transmembrane domain 
TE29 TE3 494 Protein TE29 Contains signal peptide
TE30 TE3 465 Protein TE30 Contains signal peptide 
US3A* US3 338 Serine/threonine protein kinase 
US3A 
 
US3B* US3 312 Serine/threonine protein kinase 
US3B 
 
TE31*  253 Membrane protein TE31 Type 1 membrane protein 
TE32  222 Membrane protein TE32 Type 1 membrane protein; contains Ig domain 
TE33  448 Protein TE33 Contains signal peptide 
TE34  147 Protein TE34  
US8*  465 Envelope glycoprotein E Type 1 membrane protein; involved in cell-to-cell spread 
TE35  92 Protein TE35 Contains signal peptide 
TE36  69 Protein TE36 Contains potential transmembrane domain 
US10*  248 Virion protein US10  
TE37  481 Protein TE37 Contains signal peptide 
TE38  120 Protein TE38  
TE39  94 Protein TE39 Contains potential transmembrane domains 
TE40  103 Protein TE40  
TE41 TE27 233 Protein TE41  
TE42  462 Protein TE42  
RS1*  965 Transcriptional regulator ICP4 Involved in gene regulation 
TE25 TE3 953 Protein TE25 Contains signal peptide
 
a Genes are listed as they are ordered in the genome. Duplicates (TE1, RS1, and TE25) are included. 
Asterisks mark genes that have orthologs in ChHV-5. Information on conservation in other herpesviruses is 
available in Fig. 2. 
b The names of conserved proteins, and functional annotations, are derived from NCBI reference sequences 
(http://www.ncbi.nlm.nih.gov/genomes/GenomesGroup.cgi?taxid=10292). 
 
